Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 298

1.

Correction to: Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.

Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Saigal S, Saraf N, Soin AS, Devarbhavi H, Kim DJ, Dhiman RK, Duseja A, Taneja S, Eapen CE, Goel A, Ning Q, Chen T, Ma K, Duan Z, Yu C, Treeprasertsuk S, Hamid SS, Butt AS, Jafri W, Shukla A, Saraswat V, Tan SS, Sood A, Midha V, Goyal O, Ghazinyan H, Arora A, Hu J, Sahu M, Rao PN, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Prasad VGM, Payawal DA, Abbas Z, Dokmeci AK, Sollano JD, Carpio G, Shresta A, Lau GK, Fazal Karim M, Shiha G, Gani R, Kalista KF, Yuen MF, Alam S, Khanna R, Sood V, Lal BB, Pamecha V, Jindal A, Rajan V, Arora V, Yokosuka O, Niriella MA, Li H, Qi X, Tanaka A, Mochida S, Chaudhuri DR, Gane E, Win KM, Chen WT, Rela M, Kapoor D, Rastogi A, Kale P, Rastogi A, Sharma CB, Bajpai M, Singh V, Premkumar M, Maharashi S, Olithselvan A, Philips CA, Srivastava A, Yachha SK, Wani ZA, Thapa BR, Saraya A, Shalimar, Kumar A, Wadhawan M, Gupta S, Madan K, Sakhuja P, Vij V, Sharma BC, Garg H, Garg V, Kalal C, Anand L, Vyas T, Mathur RP, Kumar G, Jain P, Pasupuleti SSR, Chawla YK, Chowdhury A, Alam S, Song DS, Yang JM, Yoon EL; APASL ACLF Research Consortium (AARC) for APASL ACLF working Party.

Hepatol Int. 2019 Oct 9. doi: 10.1007/s12072-019-09980-1. [Epub ahead of print]

PMID:
31595462
2.

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.

Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Saigal S, Saraf N, Soin AS, Devarbhavi H, Kim DJ, Dhiman RK, Duseja A, Taneja S, Eapen CE, Goel A, Ning Q, Chen T, Ma K, Duan Z, Yu C, Treeprasertsuk S, Hamid SS, Butt AS, Jafri W, Shukla A, Saraswat V, Tan SS, Sood A, Midha V, Goyal O, Ghazinyan H, Arora A, Hu J, Sahu M, Rao PN, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Prasad VGM, Payawal DA, Abbas Z, Dokmeci AK, Sollano JD, Carpio G, Shresta A, Lau GK, Fazal Karim M, Shiha G, Gani R, Kalista KF, Yuen MF, Alam S, Khanna R, Sood V, Lal BB, Pamecha V, Jindal A, Rajan V, Arora V, Yokosuka O, Niriella MA, Li H, Qi X, Tanaka A, Mochida S, Chaudhuri DR, Gane E, Win KM, Chen WT, Rela M, Kapoor D, Rastogi A, Kale P, Rastogi A, Sharma CB, Bajpai M, Singh V, Premkumar M, Maharashi S, Olithselvan A, Philips CA, Srivastava A, Yachha SK, Wani ZA, Thapa BR, Saraya A, Shalimar, Kumar A, Wadhawan M, Gupta S, Madan K, Sakhuja P, Vij V, Sharma BC, Garg H, Garg V, Kalal C, Anand L, Vyas T, Mathur RP, Kumar G, Jain P, Pasupuleti SSR, Chawla YK, Chowdhury A, Alam S, Song DS, Yang JM, Yoon EL; APASL ACLF Research Consortium (AARC) for APASL ACLF working Party.

Hepatol Int. 2019 Jul;13(4):353-390. doi: 10.1007/s12072-019-09946-3. Epub 2019 Jun 6. Erratum in: Hepatol Int. 2019 Oct 9;:.

3.

Presynaptic Calcium Channels.

Mochida S.

Int J Mol Sci. 2019 May 6;20(9). pii: E2217. doi: 10.3390/ijms20092217. Review.

4.

How the Post-Fracture Rehabilitation Choice Affects Brain Function in Older People?

Mitsuboshi N, Kouzuki M, Mochida S, Morimoto K, Urakami K.

Dement Geriatr Cogn Dis Extra. 2019 Feb 7;9(1):34-43. doi: 10.1159/000495937. eCollection 2019 Jan-Apr.

5.

Deteriorated outcome of recent patients with acute liver failure and late-onset hepatic failure caused by infection with hepatitis A virus: A subanalysis of patients seen between 1998 and 2015 and enrolled in nationwide surveys in Japan.

Nakao M, Nakayama N, Uchida Y, Tomiya T, Oketani M, Ido A, Tsubouchi H, Takikawa H, Mochida S.

Hepatol Res. 2019 Aug;49(8):844-852. doi: 10.1111/hepr.13345. Epub 2019 May 29.

PMID:
30957325
6.

A case of genotype-3b hepatitis C virus in which the whole genome was successfully analyzed using third-generation nanopore sequencing.

Uchida Y, Kouyama JI, Naiki K, Uemura H, Tsuji S, Sugawara K, Nakao M, Motoya D, Nakayama N, Imai Y, Tomiya T, Mochida S.

Hepatol Res. 2019 Sep;49(9):1083-1087. doi: 10.1111/hepr.13339. Epub 2019 Jun 13.

PMID:
30924272
7.

Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection.

Suda G, Hasebe C, Abe M, Kurosaki M, Itakura J, Izumi N, Uchida Y, Mochida S, Haga H, Ueno Y, Abe K, Takahashi A, Ohira H, Tsukuda Y, Furuya K, Baba M, Yamamoto Y, Kobayashi T, Inoue J, Terasita K, Ohara M, Kawagishi N, Izumi T, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N; NORTE Study Group.

J Gastroenterol. 2019 Jul;54(7):641-649. doi: 10.1007/s00535-019-01556-y. Epub 2019 Feb 18.

PMID:
30778716
8.

Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary Cholangitis.

Honda A, Tanaka A, Kaneko T, Komori A, Abe M, Inao M, Namisaki T, Hashimoto N, Kawata K, Takahashi A, Ninomiya M, Kang JH, Arakawa M, Yamagiwa S, Joshita S, Umemura T, Sato K, Kaneko A, Kikuchi K, Itakura J, Nomura T, Kakisaka K, Fujii H, Kawada N, Takikawa Y, Masaki T, Ohira H, Mochida S, Yoshiji H, Iimuro S, Matsuzaki Y, Takikawa H; Japan PBC Study Group.

Hepatology. 2019 Feb 8. doi: 10.1002/hep.30552. [Epub ahead of print]

PMID:
30737815
9.

NS5A-P32 deletion as a factor involved in virologic failure in patients receiving glecaprevir and pibrentasvir.

Uemura H, Uchida Y, Kouyama JI, Naiki K, Tsuji S, Sugawara K, Nakao M, Motoya D, Nakayama N, Imai Y, Tomiya T, Mochida S.

J Gastroenterol. 2019 May;54(5):459-470. doi: 10.1007/s00535-018-01543-9. Epub 2019 Jan 5.

PMID:
30612205
10.

The fission yeast Greatwall-Endosulfine pathway is required for proper quiescence/G0 phase entry and maintenance.

Aono S, Haruna Y, Watanabe YH, Mochida S, Takeda K.

Genes Cells. 2019 Feb;24(2):172-186. doi: 10.1111/gtc.12665. Epub 2019 Feb 4.

11.

Analysis of 307 cases with drug-induced liver injury between 2010 and 2018 in Japan.

Aiso M, Takikawa H, Tsuji K, Kagawa T, Watanabe M, Tanaka A, Sato K, Sakisaka S, Hiasa Y, Takei Y, Ohira H, Ayada M, Hashimoto E, Kaneko S, Ueno Y, Ohmoto K, Takaki A, Torimura T, Matsuzaki Y, Tajiri K, Yoneda M, Ito T, Kato N, Ikejima K, Mochida S, Yasuda H, Sakamoto N.

Hepatol Res. 2019 Jan;49(1):105-110. doi: 10.1111/hepr.13288.

PMID:
30565816
12.

Balloon-occluded retrograde transvenous obliteration as a procedure to improve liver function in patients with decompensated cirrhosis.

Nakazawa M, Imai Y, Uchiya H, Ando S, Sugawara K, Nakayama N, Tomiya T, Mochida S.

JGH Open. 2017 Dec 5;1(4):127-133. doi: 10.1002/jgh3.12020. eCollection 2017 Dec.

13.

Serum asunaprevir concentrations showing correlation with the extent of liver fibrosis as a factor inducing liver injuries in patients with genotype-1b hepatitis C virus receiving daclatasvir plus asunaprevir therapy.

Uchida Y, Naiki K, Kouyama JI, Sugawara K, Nakao M, Motoya D, Inao M, Nakayama N, Imai Y, Tomiya T, Mochida S.

PLoS One. 2018 Oct 11;13(10):e0205600. doi: 10.1371/journal.pone.0205600. eCollection 2018.

14.

A Model to Predict 1-Month Risk of Transplant or Death in Hepatitis A-Related Acute Liver Failure.

Kim JD, Cho EJ, Ahn C, Park SK, Choi JY, Lee HC, Kim DY, Choi MS, Wang HJ, Kim IH, Yeon JE, Seo YS, Tak WY, Kim MY, Lee HJ, Kim YS, Jun DW, Sohn JH, Kwon SY, Park SH, Heo J, Jeong SH, Lee JH, Nakayama N, Mochida S, Ido A, Tsubouchi H, Takikawa H, Shalimar, Acharya SK, Bernal W, O'Grady J, Kim YJ.

Hepatology. 2019 Aug;70(2):621-629. doi: 10.1002/hep.30262. Epub 2019 Feb 17.

PMID:
30194739
15.

A stable association with PME-1 may be dispensable for PP2A demethylation - implications for the detection of PP2A methylation and immunoprecipitation.

Yabe R, Tsuji S, Mochida S, Ikehara T, Usui T, Ohama T, Sato K.

FEBS Open Bio. 2018 Aug 1;8(9):1486-1496. doi: 10.1002/2211-5463.12485. eCollection 2018 Sep.

16.

Hepatitis E during Tocilizumab Therapy in a Patient with Rheumatoid Arthritis: Case Report and Literature Review.

Ikeuchi H, Koinuma K, Nakasatomi M, Sakairi T, Kaneko Y, Maeshima A, Yamazaki Y, Okamoto H, Mimura T, Mochida S, Nojima Y, Hiromura K.

Case Rep Rheumatol. 2018 Jul 26;2018:6873276. doi: 10.1155/2018/6873276. eCollection 2018.

17.

Sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals.

Izumi N, Takehara T, Chayama K, Yatsuhashi H, Takaguchi K, Ide T, Kurosaki M, Ueno Y, Toyoda H, Kakizaki S, Tanaka Y, Kawakami Y, Enomoto H, Ikeda F, Jiang D, De-Oertel S, McNabb BL, Camus G, Stamm LM, Brainard DM, McHutchison JG, Mochida S, Mizokami M.

Hepatol Int. 2018 Jul;12(4):356-367. doi: 10.1007/s12072-018-9878-6. Epub 2018 Jul 20.

18.

Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection.

Suda G, Kurosaki M, Itakura J, Izumi N, Uchida Y, Mochida S, Hasebe C, Abe M, Haga H, Ueno Y, Masakane I, Abe K, Takahashi A, Ohira H, Furuya K, Baba M, Yamamoto Y, Kobayashi T, Kawakami A, Kumagai K, Terasita K, Ohara M, Kawagishi N, Umemura M, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N; NORTE Study Group.

J Gastroenterol. 2019 Jan;54(1):78-86. doi: 10.1007/s00535-018-1495-6. Epub 2018 Jul 17.

PMID:
30019127
19.

Significance of NS5B Substitutions in Genotype 1b Hepatitis C Virus Evaluated by Bioinformatics Analysis.

Uchida Y, Nakamura S, Kouyama JI, Naiki K, Motoya D, Sugawara K, Inao M, Imai Y, Nakayama N, Tomiya T, Hedskog C, Brainard D, Mo H, Mochida S.

Sci Rep. 2018 Jun 11;8(1):8818. doi: 10.1038/s41598-018-27291-7.

20.

Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.

Sawai H, Nishida N, Khor SS, Honda M, Sugiyama M, Baba N, Yamada K, Sawada N, Tsugane S, Koike K, Kondo Y, Yatsuhashi H, Nagaoka S, Taketomi A, Fukai M, Kurosaki M, Izumi N, Kang JH, Murata K, Hino K, Nishina S, Matsumoto A, Tanaka E, Sakamoto N, Ogawa K, Yamamoto K, Tamori A, Yokosuka O, Kanda T, Sakaida I, Itoh Y, Eguchi Y, Oeda S, Mochida S, Yuen MF, Seto WK, Poovorawan Y, Posuwan N, Mizokami M, Tokunaga K.

Sci Rep. 2018 May 21;8(1):7958. doi: 10.1038/s41598-018-26217-7.

21.

A case of colonic varices complicated by alcoholic cirrhosis treated using balloon-occluded retrograde transvenous obliteration.

Matsumoto K, Imai Y, Takano M, Nakazawa M, Ando S, Sugawara K, Nakayama N, Tomiya T, Mochida S.

Clin J Gastroenterol. 2018 Oct;11(5):343-347. doi: 10.1007/s12328-018-0857-1. Epub 2018 Apr 25.

PMID:
29696582
22.

Proposed diagnostic criteria for acute-on-chronic liver failure in Japan.

Mochida S, Nakayama N, Ido A, Inoue K, Genda T, Takikawa Y, Sakaida I, Terai S, Yokosuka O, Shimizu M, Takikawa H.

Hepatol Res. 2018 Mar;48(4):219-224. doi: 10.1111/hepr.13066.

PMID:
29361652
23.

[Recent status of HBV reactivation in Japan and the strategy to prevent severe hepatitis].

Mochida S.

Nihon Shokakibyo Gakkai Zasshi. 2018;115(1):36-43. doi: 10.11405/nisshoshi.115.36. Japanese. No abstract available.

PMID:
29353851
24.

A multicenter pilot survey to clarify the clinical features of patients with acute-on-chronic liver failure in Japan.

Nakayama N, Uemura H, Uchida Y, Tomiya T, Ido A, Inoue K, Genda T, Takikawa Y, Sakaida I, Terai S, Yokosuka O, Shimizu M, Takikawa H, Mochida S.

Hepatol Res. 2018 Mar;48(4):303-312. doi: 10.1111/hepr.13064.

PMID:
29341357
25.

Presynaptic calcium channels.

Mochida S.

Neurosci Res. 2018 Feb;127:33-44. doi: 10.1016/j.neures.2017.09.012. Epub 2018 Jan 6. Review.

PMID:
29317246
26.

Millisecond Ca2+ dynamics activate multiple protein cascades for synaptic vesicle control.

Mochida S.

Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(10):802-820. doi: 10.2183/pjab.93.050. Review.

27.

Nationwide survey for acute liver failure and late-onset hepatic failure in Japan.

Nakao M, Nakayama N, Uchida Y, Tomiya T, Ido A, Sakaida I, Yokosuka O, Takikawa Y, Inoue K, Genda T, Shimizu M, Terai S, Tsubouchi H, Takikawa H, Mochida S.

J Gastroenterol. 2018 Jun;53(6):752-769. doi: 10.1007/s00535-017-1394-2. Epub 2017 Oct 13.

PMID:
29030713
28.

Ni-elimination from the active site of the standard [NiFe]‑hydrogenase upon oxidation by O2.

Nishikawa K, Mochida S, Hiromoto T, Shibata N, Higuchi Y.

J Inorg Biochem. 2017 Dec;177:435-437. doi: 10.1016/j.jinorgbio.2017.09.011. Epub 2017 Sep 14.

PMID:
28967475
29.

Retreatment with sofosbuvir/ledipasvir with or without lead-in interferon-β injections in patients infected with genotype 1b hepatitis C virus after unsuccessful daclatasvir/asunaprevir therapy.

Uemura H, Uchida Y, Kouyama JI, Naiki K, Yamaba S, Fuchigami A, Saito Y, Shiokawa K, Fujii Y, Uchiya H, Nakazawa M, Ando S, Nakao M, Motoya D, Sugawara K, Inao M, Imai Y, Nakayama N, Tomiya T, Mochida S.

Hepatol Res. 2018 Mar;48(4):233-243. doi: 10.1111/hepr.12980. Epub 2017 Oct 20.

PMID:
28884930
30.

Chronic hepatitis caused by hepatitis C virus showing a discrepancy between serogroup and genotype because of intergenotypic 2b/1b recombination: A pitfall in antiviral therapy with direct-acting antivirals.

Kurata H, Uchida Y, Kouyama JI, Naiki K, Nakazawa M, Ando S, Nakao M, Motoya D, Sugawara K, Inao M, Imai Y, Nakayama N, Tomiya T, Mochida S.

Hepatol Res. 2018 Feb;48(3):E372-E378. doi: 10.1111/hepr.12977. Epub 2017 Sep 25.

PMID:
28872737
31.

Efficacy and safety of telaprevir with natural human interferon-β and ribavirin in Japanese chronic hepatitis C patients with depression.

Kumada H, Mochida S, Nakamuta M, Suzuki F, Yagi T, Takasaki R, Okai M, Kamiya N, Okada Y, Hirota S, Orihashi M, Ochi M, Chayama K.

Hepatol Res. 2018 Feb;48(2):184-192. doi: 10.1111/hepr.12914. Epub 2017 Jul 19.

PMID:
28497489
32.

Short-Term Safety and Efficacy of Balloon-Occluded Retrograde Transvenous Obliteration Using Ethanolamine Oleate: Results of a Prospective, Multicenter, Single-Arm Trial.

Kobayakawa M, Kokubu S, Hirota S, Koizumi J, Nishida N, Yasumoto T, Mochida S, Hidaka H, Tanaka N, Tajima T.

J Vasc Interv Radiol. 2017 Aug;28(8):1108-1115.e2. doi: 10.1016/j.jvir.2017.03.041. Epub 2017 May 6.

33.

"Reversi-type virologic failure" involved in the development of non-structural protein 5A resistance-associated variants (RAVs) in patients with genotype 1b hepatitis C carrying no signature RAVs at baseline.

Uchida Y, Kouyama JI, Naiki K, Sugawara K, Inao M, Imai Y, Nakayama N, Mochida S.

Hepatol Res. 2017 Dec;47(13):1397-1407. doi: 10.1111/hepr.12882. Epub 2017 Apr 19.

PMID:
28239934
34.

Survival in patients with Child-Pugh class C cirrhosis: Analysis of the liver transplant registry in Japan.

Genda T, Ichida T, Sakisaka S, Tanaka E, Mochida S, Ueno Y, Inui A, Egawa H, Umeshita K, Furukawa H, Kawasaki S, Inomata Y; Assessment Committee of Indication for Transplantation.

Hepatol Res. 2017 Oct;47(11):1155-1164. doi: 10.1111/hepr.12855. Epub 2017 Jan 26.

PMID:
27995739
35.

Desflurane inhalation before ischemia increases ischemia-reperfusion-induced vascular leakage in isolated rabbit lungs.

Oshima Y, Sakamoto S, Yamasaki K, Mochida S, Funaki K, Moriyama N, Otsuki A, Endo R, Nakasone M, Takahashi S, Harada T, Minami Y, Inagaki Y.

Springerplus. 2016 Nov 29;5(1):2031. eCollection 2016.

36.

Two Bistable Switches Govern M Phase Entry.

Mochida S, Rata S, Hino H, Nagai T, Novák B.

Curr Biol. 2016 Dec 19;26(24):3361-3367. doi: 10.1016/j.cub.2016.10.022. Epub 2016 Nov 23.

37.

The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study.

Kumada H, Suzuki Y, Karino Y, Chayama K, Kawada N, Okanoue T, Itoh Y, Mochida S, Toyoda H, Yoshiji H, Takaki S, Yatsuzuka N, Yodoya E, Iwasa T, Fujimoto G, Robertson MN, Black S, Caro L, Wahl J.

J Gastroenterol. 2017 Apr;52(4):520-533. doi: 10.1007/s00535-016-1285-y. Epub 2016 Nov 21.

38.

Sequential therapy consisting of glucocorticoid infusions followed by granulocyte-monocyte absorptive apheresis in patients with severe alcoholic hepatitis.

Watanabe K, Uchida Y, Sugawara K, Naiki K, Inao M, Nakayama N, Mochida S.

J Gastroenterol. 2017 Jul;52(7):830-837. doi: 10.1007/s00535-016-1287-9. Epub 2016 Nov 17.

PMID:
27858246
39.

Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment-experienced Japanese patients with hepatitis C virus genotype 1 (GT1b) infection: Phase 3 studies.

Kumada H, Mochida S, Suzuki F, Chayama K, Karino Y, Nakamura K, Fujimoto G, Howe AY, Ludmerer SW, Mobashery N.

J Gastroenterol Hepatol. 2016 Oct;31(10):1674-1683. doi: 10.1111/jgh.13328.

PMID:
26936417
40.

SAD-B Phosphorylation of CAST Controls Active Zone Vesicle Recycling for Synaptic Depression.

Mochida S, Hida Y, Tanifuji S, Hagiwara A, Hamada S, Abe M, Ma H, Yasumura M, Kitajima I, Sakimura K, Ohtsuka T.

Cell Rep. 2016 Sep 13;16(11):2901-2913. doi: 10.1016/j.celrep.2016.08.020.

41.

[Acute Liver Failure in Japan].

Mochida S.

Nihon Naika Gakkai Zasshi. 2016 Aug;105(8):1463-71. Japanese. No abstract available.

PMID:
30168994
42.

Changing nomenclature for PBC from "Primary Biliary Cirrhosis" to "Primary Biliary Cholangitis".

Tanaka A, Takikawa H, Mochida S, Koike K, Miwa H, Shimosegawa T.

Nihon Shokakibyo Gakkai Zasshi. 2016 Jul;113(7):1165-7. doi: 10.11405/nisshoshi.113.1165. Japanese. No abstract available.

PMID:
27383098
43.

Changing Nomenclature for PBC from "Primary Biliary Cirrhosis" to "Primary Biliary Cholangitis".

Tanaka A, Takikawa H, Mochida S, Koike K, Miwa H, Shimosegawa T.

J Gastroenterol. 2016 Jul;51(7):748-9. doi: 10.1007/s00535-016-1223-z. Epub 2016 May 26. No abstract available.

PMID:
27230619
44.

Changing nomenclature for PBC from "primary biliary cirrhosis" to "primary biliary cholangitis".

Tanaka A, Takikawa H, Miwa H, Shimosegawa T, Mochida S, Koike K.

Hepatol Res. 2016 Jul;46(8):725-6. doi: 10.1111/hepr.12729. No abstract available.

PMID:
27101399
45.

Understanding of HLA-conferred susceptibility to chronic hepatitis B infection requires HLA genotyping-based association analysis.

Nishida N, Ohashi J, Khor SS, Sugiyama M, Tsuchiura T, Sawai H, Hino K, Honda M, Kaneko S, Yatsuhashi H, Yokosuka O, Koike K, Kurosaki M, Izumi N, Korenaga M, Kang JH, Tanaka E, Taketomi A, Eguchi Y, Sakamoto N, Yamamoto K, Tamori A, Sakaida I, Hige S, Itoh Y, Mochida S, Mita E, Takikawa Y, Ide T, Hiasa Y, Kojima H, Yamamoto K, Nakamura M, Saji H, Sasazuki T, Kanto T, Tokunaga K, Mizokami M.

Sci Rep. 2016 Apr 19;6:24767. doi: 10.1038/srep24767.

46.

A case of liver cirrhosis with bleeding from stomal varices successfully treated using balloon-occluded retrograde transvenous obliteration.

Takano M, Imai Y, Nakazawa M, Chikayama T, Ando S, Sugawara K, Nakayama N, Mochida S.

Clin J Gastroenterol. 2016 Jun;9(3):145-9. doi: 10.1007/s12328-016-0644-9. Epub 2016 Apr 5.

PMID:
27048279
47.

Long-term outcome of 154 patients receiving balloon-occluded retrograde transvenous obliteration for gastric fundal varices.

Imai Y, Nakazawa M, Ando S, Sugawara K, Mochida S.

J Gastroenterol Hepatol. 2016 Nov;31(11):1844-1850. doi: 10.1111/jgh.13382.

PMID:
27003222
48.

Development of rare resistance-associated variants that are extremely tolerant against NS5A inhibitors during daclatasvir/asunaprevir therapy by a two-hit mechanism.

Uchida Y, Kouyama JI, Naiki K, Sugawara K, Inao M, Imai Y, Nakayama N, Mochida S.

Hepatol Res. 2016 Nov;46(12):1234-1246. doi: 10.1111/hepr.12673. Epub 2016 Mar 30.

PMID:
26878268
49.

[Reactivation of HBV due to immunosuppressive and/or anticancer therapies].

Mochida S.

Nihon Rinsho. 2015 Dec;73 Suppl 9:546-9. Japanese. No abstract available.

PMID:
26845994
50.

Nationwide prospective and retrospective surveys for hepatitis B virus reactivation during immunosuppressive therapies.

Mochida S, Nakao M, Nakayama N, Uchida Y, Nagoshi S, Ido A, Mimura T, Harigai M, Kaneko H, Kobayashi H, Tsuchida T, Suzuki H, Ura N, Nakamura Y, Bessho M, Dan K, Kusumoto S, Sasaki Y, Fujii H, Suzuki F, Ikeda K, Yamamoto K, Takikawa H, Tsubouchi H, Mizokami M.

J Gastroenterol. 2016 Oct;51(10):999-1010. doi: 10.1007/s00535-016-1168-2. Epub 2016 Feb 1.

PMID:
26831356

Supplemental Content

Loading ...
Support Center